James Hardiman
Investor at NOETIK
San Francisco, California
Overview
Work Experience
Investor and Board Observer
2017 - Current
Decoding biology to radically improve lives Board Observer 2017 to 2020
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Raised $865,376,000.00 from NVIDIA, Laurion Capital Management, Invus, Baillie Gifford, Kinnevik, Mubadala Capital Ventures and Platinum Asset Management.
Investor and Board Director
2022
An AI-native biotechnology company harnessing self-supervised learning and human multimodal data for better precision immunotherapies.
Investor and Board Observer
2022
Investor and Board Director
2021
Developing single cell platforms to unlock a key bottleneck in immunotherapy, enabling curative treatments.
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Raised $13,000,000.00 from Foundation Capital, DCVC, Jasper Lau, AV8 Ventures and Mei Z..
Investor and Board Observer
2021
Ammonia-to-power for a sustainably-driven future
Amogy offers an innovative clean energy system using ammonia as a renewable fuel.
Raised $219,300,000.00 from Mitsubishi Corporation, Mitsubishi Heavy Industries, Aramco Ventures, Zeon Ventures, DCVC, Yanmar Ventures, Korea Zinc, AP Ventures, SK Innovation and Temasek Holdings.
Investor and Board Director
2020
The world's first accessible X-Ray CT scanner for engineers
Lumafield is an accessible X-ray CT platform that gives engineers better insights into product development and manufacturing.
Raised $67,500,000.00 from Shane Neman, Spark Capital, Lux Capital, Kleiner Perkins, Future Shape and DataCollective.
Investor and Board Director
2020
Transforming how software is built and shipped.
Investor and Board Director
2020
Investor and Board Observer
2018
Builds infrastructure software to power quantum technology
Investor and Board Observer
2017
The world’s most extensive agriculture data platform